KR100540537B1 - 간경변의 치료방법 - Google Patents

간경변의 치료방법 Download PDF

Info

Publication number
KR100540537B1
KR100540537B1 KR1019997010803A KR19997010803A KR100540537B1 KR 100540537 B1 KR100540537 B1 KR 100540537B1 KR 1019997010803 A KR1019997010803 A KR 1019997010803A KR 19997010803 A KR19997010803 A KR 19997010803A KR 100540537 B1 KR100540537 B1 KR 100540537B1
Authority
KR
South Korea
Prior art keywords
halofuginone
liver
collagen
cirrhosis
pharmaceutically acceptable
Prior art date
Application number
KR1019997010803A
Other languages
English (en)
Korean (ko)
Other versions
KR20010012838A (ko
Inventor
피네스마르크
나글러아르논
Original Assignee
하다시트 메디칼 리서치 서비시즈 앤드 디벨롭먼트 캄파니 리미티드
어그리컬츄럴 리서치 오가니제이션
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25338371&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR100540537(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 하다시트 메디칼 리서치 서비시즈 앤드 디벨롭먼트 캄파니 리미티드, 어그리컬츄럴 리서치 오가니제이션 filed Critical 하다시트 메디칼 리서치 서비시즈 앤드 디벨롭먼트 캄파니 리미티드
Publication of KR20010012838A publication Critical patent/KR20010012838A/ko
Application granted granted Critical
Publication of KR100540537B1 publication Critical patent/KR100540537B1/ko

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1019997010803A 1997-05-23 1998-05-22 간경변의 치료방법 KR100540537B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86238297A 1997-05-23 1997-05-23
US08/862,382 1997-05-23
PCT/US1998/010505 WO1998052514A2 (fr) 1997-05-23 1998-05-22 Traitement de la cirrhose hepatique

Publications (2)

Publication Number Publication Date
KR20010012838A KR20010012838A (ko) 2001-02-26
KR100540537B1 true KR100540537B1 (ko) 2006-01-10

Family

ID=25338371

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019997010803A KR100540537B1 (ko) 1997-05-23 1998-05-22 간경변의 치료방법

Country Status (8)

Country Link
EP (1) EP1014988A2 (fr)
JP (1) JP2002515905A (fr)
KR (1) KR100540537B1 (fr)
CN (1) CN1160073C (fr)
AU (1) AU748754B2 (fr)
CA (1) CA2290502C (fr)
IL (1) IL132848A (fr)
WO (1) WO1998052514A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060258692A1 (en) * 2002-10-31 2006-11-16 Mark Pines Quinazolinone compositions for regulation of gene expression related to pathological processes

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449678A (en) * 1994-01-11 1995-09-12 Agricultural Research Organization, Ministry Of Agriculture Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3320124A (en) * 1964-07-20 1967-05-16 American Cyanamid Co Method for treating coccidiosis with quinazolinones

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449678A (en) * 1994-01-11 1995-09-12 Agricultural Research Organization, Ministry Of Agriculture Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof

Also Published As

Publication number Publication date
CN1160073C (zh) 2004-08-04
WO1998052514A3 (fr) 1999-08-19
AU748754B2 (en) 2002-06-13
CA2290502C (fr) 2007-08-28
IL132848A0 (en) 2001-03-19
WO1998052514A2 (fr) 1998-11-26
CN1265034A (zh) 2000-08-30
IL132848A (en) 2004-08-31
CA2290502A1 (fr) 1998-11-26
EP1014988A2 (fr) 2000-07-05
KR20010012838A (ko) 2001-02-26
JP2002515905A (ja) 2002-05-28
AU7692298A (en) 1998-12-11

Similar Documents

Publication Publication Date Title
US20060009397A1 (en) New use
US20080058303A1 (en) Use of melagatran
JP2001511176A (ja) 癒着の治療および予防
MXPA02004871A (es) Combinaciones farmaceuticas.
CA2568436A1 (fr) Therapie combinee impliquant un antagoniste de recepteur d'adenosine a1 et un inhibiteur d'aldosterone
US6562829B1 (en) Treatment of hepatic cirrhosis
MXPA00012808A (es) El uso de analogo de acido valproico para tratamiento y prevencion de migrana y enfermedad afectiva.
KR100540537B1 (ko) 간경변의 치료방법
US5872124A (en) Treatment of diseases of the central nervous system using uric acid as a scavenger of peroxynitrite
JP2004534760A (ja) 腎線維症の治療
CA3234847A1 (fr) Nouvelle composition pharmaceutique orale et schema posologique pour le traitement des pneumopathies interstitielles fibrosantes progressives
RU2339381C2 (ru) Ингибитор гиперплазии интимы сосудов
US20140288102A1 (en) Prevention of recurrences of urethral strictures following conventional therapy
AU737094B2 (en) Treatment for pulmonary fibrosis
EP1795193B1 (fr) Histidine pour supprimer la necrose des tissus cerebraux attribues a une ischemie de longue duree
AU2002366975B2 (en) Quinazolinone compounds in combined modalities for improved cancer treatment
JP5011496B2 (ja) 脳梗塞抑制剤
JP2000514064A (ja) 敗血症誘導性急性腎不全および腎血管収縮ならびにカテコールアミン誘導性腎および腸管膜血管収縮の治療
EP1120408A9 (fr) Remedes du dysfonctionnement moteur et inhibiteurs de l'expression de gapdh
AU2014262206A1 (en) Prevention of recurrence of urethral stricture after a conventional treatment

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee